tirzepatide once a week 9 on ๐, This week the scale was up 0.8 pounds., Iโve decided that, for my own mental health, Iโm only going to share my weight every two weeks instead of every week. Weight loss isnโt Weekly GLP-1 Injection vs Daily
Description
CagriSema injection is a long-acting combination therapy under development by Novo Nordisk, the main components are GLP-1 (glucagon-like peptide-1) receptor agonist smeglutide and a long-acting amylin analog cagrilintide

Those who took tirzepatide experienced significant weight loss compared to those who received a placebo

Safety and Oral Wegovy Side Effects Safety is a priority in weight loss treatments

Clinical studies reveal a significant weight loss of 14.9% to 17.4% of body weight over 68 weeks, much more than typical diet and exercise results alone

The combination is also effective for patients with diabetes, kidney disease, or cardiovascular disease who require tight blood pressure control to prevent complications

Nausea During Stimulation GLP-1 nausea is the most common complaint
